nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2B6—Ifosfamide—germ cell cancer	0.104	0.2	CbGbCtD
Paroxetine—CYP2C8—Ifosfamide—germ cell cancer	0.0786	0.151	CbGbCtD
Paroxetine—CYP2C9—Ifosfamide—germ cell cancer	0.0548	0.105	CbGbCtD
Paroxetine—CYP2B6—Cisplatin—germ cell cancer	0.0505	0.0971	CbGbCtD
Paroxetine—ABCB1—Dactinomycin—germ cell cancer	0.0451	0.0867	CbGbCtD
Paroxetine—CYP2C8—Etoposide—germ cell cancer	0.0376	0.0723	CbGbCtD
Paroxetine—ABCB1—Vinblastine—germ cell cancer	0.0282	0.0543	CbGbCtD
Paroxetine—CYP2C9—Cisplatin—germ cell cancer	0.0267	0.0513	CbGbCtD
Paroxetine—CYP2D6—Vinblastine—germ cell cancer	0.0266	0.0512	CbGbCtD
Paroxetine—ABCB1—Cisplatin—germ cell cancer	0.0259	0.0498	CbGbCtD
Paroxetine—ABCB1—Etoposide—germ cell cancer	0.0254	0.0489	CbGbCtD
Paroxetine—ABCB1—Methotrexate—germ cell cancer	0.0168	0.0323	CbGbCtD
Paroxetine—TACR1—trigeminal nerve—germ cell cancer	0.0134	0.0783	CbGeAlD
Paroxetine—TACR1—vagus nerve—germ cell cancer	0.0125	0.0732	CbGeAlD
Paroxetine—CYP2C9—cardial valve—germ cell cancer	0.00974	0.0568	CbGeAlD
Paroxetine—TACR1—cranial nerve—germ cell cancer	0.00955	0.0558	CbGeAlD
Paroxetine—HTR2A—phrenic nerve—germ cell cancer	0.00894	0.0522	CbGeAlD
Paroxetine—HTR2A—choroid plexus—germ cell cancer	0.00647	0.0377	CbGeAlD
Paroxetine—TACR1—ganglion—germ cell cancer	0.00484	0.0282	CbGeAlD
Paroxetine—HTR2A—myenteric nerve plexus—germ cell cancer	0.00459	0.0268	CbGeAlD
Paroxetine—CHRM5—skin epidermis—germ cell cancer	0.00422	0.0246	CbGeAlD
Paroxetine—SLC6A3—telencephalic ventricle—germ cell cancer	0.00391	0.0228	CbGeAlD
Paroxetine—HTR2A—trigeminal nerve—germ cell cancer	0.00327	0.0191	CbGeAlD
Paroxetine—HTR2A—vagus nerve—germ cell cancer	0.00306	0.0179	CbGeAlD
Paroxetine—SLC6A3—ganglion—germ cell cancer	0.00243	0.0142	CbGeAlD
Paroxetine—HTR2A—cranial nerve—germ cell cancer	0.00233	0.0136	CbGeAlD
Paroxetine—HTR2A—pons—germ cell cancer	0.0023	0.0134	CbGeAlD
Paroxetine—SLC6A4—ganglion—germ cell cancer	0.00223	0.013	CbGeAlD
Paroxetine—TACR1—brainstem—germ cell cancer	0.0021	0.0123	CbGeAlD
Paroxetine—CYP2C9—urine—germ cell cancer	0.0021	0.0123	CbGeAlD
Paroxetine—SLC6A2—ganglion—germ cell cancer	0.00196	0.0115	CbGeAlD
Paroxetine—HTR2A—telencephalic ventricle—germ cell cancer	0.00189	0.0111	CbGeAlD
Paroxetine—TACR1—telencephalon—germ cell cancer	0.00187	0.0109	CbGeAlD
Paroxetine—HTR2A—urine—germ cell cancer	0.00173	0.0101	CbGeAlD
Paroxetine—HTR2A—appendage—germ cell cancer	0.00168	0.00983	CbGeAlD
Paroxetine—HTR2A—pineal body—germ cell cancer	0.00164	0.00959	CbGeAlD
Paroxetine—CYP2D6—urine—germ cell cancer	0.00158	0.0092	CbGeAlD
Paroxetine—CHRM5—eye—germ cell cancer	0.0015	0.00878	CbGeAlD
Paroxetine—TACR1—adrenal gland—germ cell cancer	0.00136	0.00792	CbGeAlD
Paroxetine—CHRM5—skin of body—germ cell cancer	0.00131	0.00764	CbGeAlD
Paroxetine—TACR1—spinal cord—germ cell cancer	0.00131	0.00763	CbGeAlD
Paroxetine—HTR2A—ganglion—germ cell cancer	0.00118	0.00688	CbGeAlD
Paroxetine—TACR1—endocrine gland—germ cell cancer	0.00118	0.00687	CbGeAlD
Paroxetine—TACR1—head—germ cell cancer	0.00116	0.00678	CbGeAlD
Paroxetine—TACR1—testis—germ cell cancer	0.00112	0.00655	CbGeAlD
Paroxetine—CHRM4—head—germ cell cancer	0.00109	0.00637	CbGeAlD
Paroxetine—SLC6A3—brainstem—germ cell cancer	0.00106	0.00617	CbGeAlD
Paroxetine—CHRM4—testis—germ cell cancer	0.00105	0.00616	CbGeAlD
Paroxetine—HTR2A—endothelium—germ cell cancer	0.00102	0.00593	CbGeAlD
Paroxetine—SLC6A4—brainstem—germ cell cancer	0.000969	0.00565	CbGeAlD
Paroxetine—CHRM2—telencephalon—germ cell cancer	0.000941	0.00549	CbGeAlD
Paroxetine—SLC6A3—telencephalon—germ cell cancer	0.000938	0.00548	CbGeAlD
Paroxetine—HTR2A—blood vessel—germ cell cancer	0.000938	0.00547	CbGeAlD
Paroxetine—SLC6A4—telencephalon—germ cell cancer	0.00086	0.00502	CbGeAlD
Paroxetine—CHRM1—telencephalon—germ cell cancer	0.000856	0.005	CbGeAlD
Paroxetine—CHRM5—head—germ cell cancer	0.000854	0.00498	CbGeAlD
Paroxetine—SLC6A2—brainstem—germ cell cancer	0.000853	0.00498	CbGeAlD
Paroxetine—TACR1—brain—germ cell cancer	0.000842	0.00491	CbGeAlD
Paroxetine—TACR1—lymph node—germ cell cancer	0.000813	0.00475	CbGeAlD
Paroxetine—CHRM4—brain—germ cell cancer	0.000791	0.00462	CbGeAlD
Paroxetine—CHRM3—telencephalon—germ cell cancer	0.000766	0.00447	CbGeAlD
Paroxetine—SLC6A2—telencephalon—germ cell cancer	0.000757	0.00442	CbGeAlD
Paroxetine—SLC6A2—decidua—germ cell cancer	0.000717	0.00419	CbGeAlD
Paroxetine—TACR1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000706	0.0305	CbGpPWpGaD
Paroxetine—SLC6A3—midbrain—germ cell cancer	0.000674	0.00393	CbGeAlD
Paroxetine—HTR2A—neck—germ cell cancer	0.000671	0.00392	CbGeAlD
Paroxetine—SLC6A3—spinal cord—germ cell cancer	0.000657	0.00384	CbGeAlD
Paroxetine—SLC6A3—Monoamine Transport—PVRL2—germ cell cancer	0.000636	0.0275	CbGpPWpGaD
Paroxetine—SLC6A2—gonad—germ cell cancer	0.000632	0.00369	CbGeAlD
Paroxetine—SLC6A4—Synaptic Vesicle Pathway—SLC22A3—germ cell cancer	0.000623	0.0269	CbGpPWpGaD
Paroxetine—CHRM5—brain—germ cell cancer	0.000619	0.00361	CbGeAlD
Paroxetine—SLC6A4—midbrain—germ cell cancer	0.000617	0.0036	CbGeAlD
Paroxetine—ABCB1—blood vessel—germ cell cancer	0.000614	0.00359	CbGeAlD
Paroxetine—SLC6A4—spinal cord—germ cell cancer	0.000602	0.00352	CbGeAlD
Paroxetine—SLC6A2—medulla oblongata—germ cell cancer	0.000595	0.00347	CbGeAlD
Paroxetine—CHRM2—endocrine gland—germ cell cancer	0.000593	0.00346	CbGeAlD
Paroxetine—CHRM2—head—germ cell cancer	0.000586	0.00342	CbGeAlD
Paroxetine—SLC6A3—head—germ cell cancer	0.000584	0.00341	CbGeAlD
Paroxetine—SLC6A3—Dopaminergic Neurogenesis—SOX2—germ cell cancer	0.000577	0.0249	CbGpPWpGaD
Paroxetine—SLC6A3—testis—germ cell cancer	0.000564	0.00329	CbGeAlD
Paroxetine—HTR2A—embryo—germ cell cancer	0.000559	0.00326	CbGeAlD
Paroxetine—SLC6A2—adrenal gland—germ cell cancer	0.000551	0.00321	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—germ cell cancer	0.000542	0.00317	CbGeAlD
Paroxetine—CHRM1—endocrine gland—germ cell cancer	0.00054	0.00315	CbGeAlD
Paroxetine—SLC6A4—head—germ cell cancer	0.000535	0.00312	CbGeAlD
Paroxetine—CHRM1—head—germ cell cancer	0.000533	0.00311	CbGeAlD
Paroxetine—CYP2B6—skin of body—germ cell cancer	0.000532	0.00311	CbGeAlD
Paroxetine—SLC6A3—cerebellum—germ cell cancer	0.000521	0.00304	CbGeAlD
Paroxetine—CHRM3—female gonad—germ cell cancer	0.00052	0.00303	CbGeAlD
Paroxetine—HTR2A—brainstem—germ cell cancer	0.000513	0.00299	CbGeAlD
Paroxetine—CYP2C8—pituitary gland—germ cell cancer	0.000506	0.00295	CbGeAlD
Paroxetine—HTR2A—eye—germ cell cancer	0.000499	0.00291	CbGeAlD
Paroxetine—HTR2A—retina—germ cell cancer	0.000495	0.00289	CbGeAlD
Paroxetine—CHRM3—endocrine gland—germ cell cancer	0.000483	0.00282	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—germ cell cancer	0.000477	0.00279	CbGeAlD
Paroxetine—CHRM3—head—germ cell cancer	0.000477	0.00279	CbGeAlD
Paroxetine—SLC6A2—head—germ cell cancer	0.000471	0.00275	CbGeAlD
Paroxetine—CYP2D6—brainstem—germ cell cancer	0.000467	0.00273	CbGeAlD
Paroxetine—CYP2B6—gonad—germ cell cancer	0.000465	0.00272	CbGeAlD
Paroxetine—CHRM3—testis—germ cell cancer	0.000461	0.00269	CbGeAlD
Paroxetine—SLC6A2—testis—germ cell cancer	0.000455	0.00266	CbGeAlD
Paroxetine—HTR2A—telencephalon—germ cell cancer	0.000455	0.00266	CbGeAlD
Paroxetine—CYP2B6—Metapathway biotransformation—NAT9—germ cell cancer	0.000446	0.0193	CbGpPWpGaD
Paroxetine—CHRM2—brain—germ cell cancer	0.000425	0.00248	CbGeAlD
Paroxetine—SLC6A3—brain—germ cell cancer	0.000423	0.00247	CbGeAlD
Paroxetine—CYP2D6—telencephalon—germ cell cancer	0.000414	0.00242	CbGeAlD
Paroxetine—CYP2B6—adrenal gland—germ cell cancer	0.000406	0.00237	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—germ cell cancer	0.000392	0.00229	CbGeAlD
Paroxetine—TACR1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000391	0.0169	CbGpPWpGaD
Paroxetine—SLC6A4—brain—germ cell cancer	0.000388	0.00226	CbGeAlD
Paroxetine—CHRM1—brain—germ cell cancer	0.000386	0.00226	CbGeAlD
Paroxetine—HTR2A—gonad—germ cell cancer	0.00038	0.00222	CbGeAlD
Paroxetine—ABCB1—trigeminal ganglion—germ cell cancer	0.00038	0.00222	CbGeAlD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000379	0.0164	CbGpPWpGaD
Paroxetine—CYP2C8—Metapathway biotransformation—NAT9—germ cell cancer	0.000378	0.0163	CbGpPWpGaD
Paroxetine—CYP2C8—testis—germ cell cancer	0.000374	0.00218	CbGeAlD
Paroxetine—HTR2A—pituitary gland—germ cell cancer	0.00037	0.00216	CbGeAlD
Paroxetine—ABCB1—embryo—germ cell cancer	0.000367	0.00214	CbGeAlD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000365	0.0158	CbGpPWpGaD
Paroxetine—HTR2A—medulla oblongata—germ cell cancer	0.000357	0.00209	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—germ cell cancer	0.000352	0.00205	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—germ cell cancer	0.000348	0.00203	CbGeAlD
Paroxetine—CYP2B6—head—germ cell cancer	0.000347	0.00203	CbGeAlD
Paroxetine—CHRM3—brain—germ cell cancer	0.000346	0.00202	CbGeAlD
Paroxetine—SLC6A2—brain—germ cell cancer	0.000342	0.00199	CbGeAlD
Paroxetine—CYP2B6—testis—germ cell cancer	0.000335	0.00196	CbGeAlD
Paroxetine—HTR2A—adrenal gland—germ cell cancer	0.000331	0.00193	CbGeAlD
Paroxetine—SLC6A2—lymph node—germ cell cancer	0.00033	0.00193	CbGeAlD
Paroxetine—HTR2A—midbrain—germ cell cancer	0.000327	0.00191	CbGeAlD
Paroxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000325	0.0141	CbGpPWpGaD
Paroxetine—ABCB1—retina—germ cell cancer	0.000324	0.00189	CbGeAlD
Paroxetine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00032	0.0138	CbGpPWpGaD
Paroxetine—HTR2A—spinal cord—germ cell cancer	0.000319	0.00186	CbGeAlD
Paroxetine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.00031	0.0134	CbGpPWpGaD
Paroxetine—CYP2C9—Metapathway biotransformation—NAT9—germ cell cancer	0.000307	0.0133	CbGpPWpGaD
Paroxetine—ABCB1—telencephalon—germ cell cancer	0.000298	0.00174	CbGeAlD
Paroxetine—TACR1—G alpha (q) signalling events—OXT—germ cell cancer	0.000291	0.0126	CbGpPWpGaD
Paroxetine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000288	0.0125	CbGpPWpGaD
Paroxetine—TACR1—Peptide ligand-binding receptors—OXT—germ cell cancer	0.000287	0.0124	CbGpPWpGaD
Paroxetine—HTR2A—endocrine gland—germ cell cancer	0.000287	0.00167	CbGeAlD
Paroxetine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000284	0.0123	CbGpPWpGaD
Paroxetine—HTR2A—head—germ cell cancer	0.000283	0.00165	CbGeAlD
Paroxetine—ABCB1—decidua—germ cell cancer	0.000283	0.00165	CbGeAlD
Paroxetine—CYP2D6—female gonad—germ cell cancer	0.000281	0.00164	CbGeAlD
Paroxetine—CYP2C8—brain—germ cell cancer	0.000281	0.00164	CbGeAlD
Paroxetine—HTR2A—testis—germ cell cancer	0.000274	0.0016	CbGeAlD
Paroxetine—SLC6A4—NRF2 pathway—SLC2A3—germ cell cancer	0.000273	0.0118	CbGpPWpGaD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000266	0.00093	CcSEcCtD
Paroxetine—Flushing—Etoposide—germ cell cancer	0.000265	0.000927	CcSEcCtD
Paroxetine—Cardiac disorder—Etoposide—germ cell cancer	0.000265	0.000927	CcSEcCtD
Paroxetine—Discomfort—Ifosfamide—germ cell cancer	0.000264	0.000926	CcSEcCtD
Paroxetine—Hypersensitivity—Vinblastine—germ cell cancer	0.000262	0.000917	CcSEcCtD
Paroxetine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000262	0.000916	CcSEcCtD
Paroxetine—CYP2D6—endocrine gland—germ cell cancer	0.000261	0.00153	CbGeAlD
Paroxetine—Decreased appetite—Bleomycin—germ cell cancer	0.000261	0.000913	CcSEcCtD
Paroxetine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.00026	0.0113	CbGpPWpGaD
Paroxetine—Visual disturbance—Methotrexate—germ cell cancer	0.00026	0.000912	CcSEcCtD
Paroxetine—Muscle spasms—Cisplatin—germ cell cancer	0.00026	0.000912	CcSEcCtD
Paroxetine—Angiopathy—Etoposide—germ cell cancer	0.000259	0.000906	CcSEcCtD
Paroxetine—Confusional state—Ifosfamide—germ cell cancer	0.000258	0.000905	CcSEcCtD
Paroxetine—CYP2D6—head—germ cell cancer	0.000258	0.00151	CbGeAlD
Paroxetine—Immune system disorder—Etoposide—germ cell cancer	0.000257	0.000902	CcSEcCtD
Paroxetine—Mediastinal disorder—Etoposide—germ cell cancer	0.000257	0.0009	CcSEcCtD
Paroxetine—Pain—Bleomycin—germ cell cancer	0.000257	0.000899	CcSEcCtD
Paroxetine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000256	0.000898	CcSEcCtD
Paroxetine—Oedema—Ifosfamide—germ cell cancer	0.000256	0.000898	CcSEcCtD
Paroxetine—Chills—Etoposide—germ cell cancer	0.000256	0.000896	CcSEcCtD
Paroxetine—Vision blurred—Cisplatin—germ cell cancer	0.000255	0.000894	CcSEcCtD
Paroxetine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000255	0.000893	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000255	0.000893	CcSEcCtD
Paroxetine—Asthenia—Vinblastine—germ cell cancer	0.000255	0.000893	CcSEcCtD
Paroxetine—Infection—Ifosfamide—germ cell cancer	0.000255	0.000892	CcSEcCtD
Paroxetine—Tremor—Cisplatin—germ cell cancer	0.000254	0.000889	CcSEcCtD
Paroxetine—HTR2A—cerebellum—germ cell cancer	0.000253	0.00148	CbGeAlD
Paroxetine—Alopecia—Etoposide—germ cell cancer	0.000252	0.000882	CcSEcCtD
Paroxetine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000252	0.000882	CcSEcCtD
Paroxetine—Lethargy—Methotrexate—germ cell cancer	0.000252	0.000882	CcSEcCtD
Paroxetine—CYP2B6—brain—germ cell cancer	0.000252	0.00147	CbGeAlD
Paroxetine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000251	0.000881	CcSEcCtD
Paroxetine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000251	0.00088	CcSEcCtD
Paroxetine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000251	0.000879	CcSEcCtD
Paroxetine—Anaemia—Cisplatin—germ cell cancer	0.00025	0.000877	CcSEcCtD
Paroxetine—CYP2D6—testis—germ cell cancer	0.000249	0.00146	CbGeAlD
Paroxetine—Skin disorder—Ifosfamide—germ cell cancer	0.000249	0.000872	CcSEcCtD
Paroxetine—ABCB1—gonad—germ cell cancer	0.000249	0.00145	CbGeAlD
Paroxetine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000248	0.000868	CcSEcCtD
Paroxetine—Feeling abnormal—Bleomycin—germ cell cancer	0.000247	0.000866	CcSEcCtD
Paroxetine—ABCB1—uterus—germ cell cancer	0.000247	0.00144	CbGeAlD
Paroxetine—Osteoarthritis—Methotrexate—germ cell cancer	0.000247	0.000864	CcSEcCtD
Paroxetine—Malaise—Cisplatin—germ cell cancer	0.000244	0.000855	CcSEcCtD
Paroxetine—Decreased appetite—Dactinomycin—germ cell cancer	0.000243	0.000852	CcSEcCtD
Paroxetine—Diarrhoea—Vinblastine—germ cell cancer	0.000243	0.000851	CcSEcCtD
Paroxetine—Dysgeusia—Etoposide—germ cell cancer	0.000243	0.000851	CcSEcCtD
Paroxetine—ABCB1—pituitary gland—germ cell cancer	0.000243	0.00142	CbGeAlD
Paroxetine—Leukopenia—Cisplatin—germ cell cancer	0.000242	0.000849	CcSEcCtD
Paroxetine—Fatigue—Dactinomycin—germ cell cancer	0.000241	0.000845	CcSEcCtD
Paroxetine—Back pain—Etoposide—germ cell cancer	0.00024	0.000841	CcSEcCtD
Paroxetine—Hypotension—Ifosfamide—germ cell cancer	0.00024	0.000839	CcSEcCtD
Paroxetine—Pain—Dactinomycin—germ cell cancer	0.000239	0.000838	CcSEcCtD
Paroxetine—Muscle spasms—Etoposide—germ cell cancer	0.000239	0.000836	CcSEcCtD
Paroxetine—Urticaria—Bleomycin—germ cell cancer	0.000238	0.000835	CcSEcCtD
Paroxetine—Body temperature increased—Bleomycin—germ cell cancer	0.000237	0.000831	CcSEcCtD
Paroxetine—Dizziness—Vinblastine—germ cell cancer	0.000235	0.000823	CcSEcCtD
Paroxetine—Convulsion—Cisplatin—germ cell cancer	0.000235	0.000822	CcSEcCtD
Paroxetine—SLC6A2—NRF2 pathway—SLC2A3—germ cell cancer	0.000235	0.0101	CbGpPWpGaD
Paroxetine—ABCB1—medulla oblongata—germ cell cancer	0.000234	0.00137	CbGeAlD
Paroxetine—Mood swings—Methotrexate—germ cell cancer	0.000234	0.000819	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000234	0.000818	CcSEcCtD
Paroxetine—Ataxia—Methotrexate—germ cell cancer	0.000232	0.000813	CcSEcCtD
Paroxetine—TACR1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000231	0.00997	CbGpPWpGaD
Paroxetine—Myalgia—Cisplatin—germ cell cancer	0.000231	0.000808	CcSEcCtD
Paroxetine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000231	0.000808	CcSEcCtD
Paroxetine—CYP2D6—cerebellum—germ cell cancer	0.00023	0.00134	CbGeAlD
Paroxetine—Paraesthesia—Ifosfamide—germ cell cancer	0.00023	0.000806	CcSEcCtD
Paroxetine—Ill-defined disorder—Etoposide—germ cell cancer	0.00023	0.000806	CcSEcCtD
Paroxetine—Anxiety—Cisplatin—germ cell cancer	0.00023	0.000805	CcSEcCtD
Paroxetine—Anaemia—Etoposide—germ cell cancer	0.000229	0.000803	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000229	0.000802	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000229	0.000801	CcSEcCtD
Paroxetine—Dyspnoea—Ifosfamide—germ cell cancer	0.000229	0.000801	CcSEcCtD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000228	0.00986	CbGpPWpGaD
Paroxetine—Somnolence—Ifosfamide—germ cell cancer	0.000228	0.000798	CcSEcCtD
Paroxetine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000228	0.000798	CcSEcCtD
Paroxetine—Discomfort—Cisplatin—germ cell cancer	0.000228	0.000798	CcSEcCtD
Paroxetine—Vomiting—Vinblastine—germ cell cancer	0.000226	0.000791	CcSEcCtD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000224	0.00968	CbGpPWpGaD
Paroxetine—Malaise—Etoposide—germ cell cancer	0.000224	0.000784	CcSEcCtD
Paroxetine—Breast disorder—Methotrexate—germ cell cancer	0.000223	0.000781	CcSEcCtD
Paroxetine—Vertigo—Etoposide—germ cell cancer	0.000223	0.000781	CcSEcCtD
Paroxetine—Decreased appetite—Ifosfamide—germ cell cancer	0.000223	0.000781	CcSEcCtD
Paroxetine—Headache—Vinblastine—germ cell cancer	0.000223	0.000779	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000222	0.000778	CcSEcCtD
Paroxetine—Leukopenia—Etoposide—germ cell cancer	0.000222	0.000778	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000221	0.000775	CcSEcCtD
Paroxetine—Body temperature increased—Dactinomycin—germ cell cancer	0.000221	0.000775	CcSEcCtD
Paroxetine—Abdominal pain—Dactinomycin—germ cell cancer	0.000221	0.000775	CcSEcCtD
Paroxetine—Fatigue—Ifosfamide—germ cell cancer	0.000221	0.000774	CcSEcCtD
Paroxetine—Oedema—Cisplatin—germ cell cancer	0.000221	0.000774	CcSEcCtD
Paroxetine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000221	0.000774	CcSEcCtD
Paroxetine—Hypersensitivity—Bleomycin—germ cell cancer	0.000221	0.000774	CcSEcCtD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00022	0.00949	CbGpPWpGaD
Paroxetine—Infection—Cisplatin—germ cell cancer	0.00022	0.000769	CcSEcCtD
Paroxetine—Constipation—Ifosfamide—germ cell cancer	0.000219	0.000768	CcSEcCtD
Paroxetine—Pain—Ifosfamide—germ cell cancer	0.000219	0.000768	CcSEcCtD
Paroxetine—Loss of consciousness—Etoposide—germ cell cancer	0.000218	0.000764	CcSEcCtD
Paroxetine—ABCB1—adrenal gland—germ cell cancer	0.000217	0.00127	CbGeAlD
Paroxetine—Nervous system disorder—Cisplatin—germ cell cancer	0.000217	0.000759	CcSEcCtD
Paroxetine—Cough—Etoposide—germ cell cancer	0.000216	0.000758	CcSEcCtD
Paroxetine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000216	0.000758	CcSEcCtD
Paroxetine—Tachycardia—Cisplatin—germ cell cancer	0.000216	0.000756	CcSEcCtD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000216	0.00932	CbGpPWpGaD
Paroxetine—Asthenia—Bleomycin—germ cell cancer	0.000215	0.000754	CcSEcCtD
Paroxetine—Convulsion—Etoposide—germ cell cancer	0.000215	0.000753	CcSEcCtD
Paroxetine—Skin disorder—Cisplatin—germ cell cancer	0.000215	0.000752	CcSEcCtD
Paroxetine—Hypertension—Etoposide—germ cell cancer	0.000214	0.00075	CcSEcCtD
Paroxetine—ABCB1—midbrain—germ cell cancer	0.000214	0.00125	CbGeAlD
Paroxetine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000214	0.000748	CcSEcCtD
Paroxetine—Asthma—Methotrexate—germ cell cancer	0.000213	0.000747	CcSEcCtD
Paroxetine—Pruritus—Bleomycin—germ cell cancer	0.000212	0.000743	CcSEcCtD
Paroxetine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000211	0.00074	CcSEcCtD
Paroxetine—Chest pain—Etoposide—germ cell cancer	0.000211	0.00074	CcSEcCtD
Paroxetine—Eosinophilia—Methotrexate—germ cell cancer	0.000211	0.00074	CcSEcCtD
Paroxetine—Nausea—Vinblastine—germ cell cancer	0.000211	0.000739	CcSEcCtD
Paroxetine—ABCB1—bone marrow—germ cell cancer	0.00021	0.00122	CbGeAlD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00021	0.000735	CcSEcCtD
Paroxetine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00021	0.000734	CcSEcCtD
Paroxetine—Pancreatitis—Methotrexate—germ cell cancer	0.000209	0.000732	CcSEcCtD
Paroxetine—ABCB1—spinal cord—germ cell cancer	0.000209	0.00122	CbGeAlD
Paroxetine—Discomfort—Etoposide—germ cell cancer	0.000209	0.000731	CcSEcCtD
Paroxetine—SLC6A3—NRF2 pathway—SLC2A3—germ cell cancer	0.000208	0.00898	CbGpPWpGaD
Paroxetine—Hypotension—Cisplatin—germ cell cancer	0.000207	0.000723	CcSEcCtD
Paroxetine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000206	0.000722	CcSEcCtD
Paroxetine—HTR2A—brain—germ cell cancer	0.000205	0.0012	CbGeAlD
Paroxetine—Confusional state—Etoposide—germ cell cancer	0.000204	0.000715	CcSEcCtD
Paroxetine—Urticaria—Ifosfamide—germ cell cancer	0.000204	0.000713	CcSEcCtD
Paroxetine—Abdominal pain—Ifosfamide—germ cell cancer	0.000203	0.00071	CcSEcCtD
Paroxetine—Body temperature increased—Ifosfamide—germ cell cancer	0.000203	0.00071	CcSEcCtD
Paroxetine—Pancytopenia—Methotrexate—germ cell cancer	0.000203	0.000709	CcSEcCtD
Paroxetine—Anaphylactic shock—Etoposide—germ cell cancer	0.000202	0.000709	CcSEcCtD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000202	0.00875	CbGpPWpGaD
Paroxetine—ABCB1—female gonad—germ cell cancer	0.000202	0.00118	CbGeAlD
Paroxetine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000201	0.000705	CcSEcCtD
Paroxetine—Infection—Etoposide—germ cell cancer	0.000201	0.000705	CcSEcCtD
Paroxetine—Asthenia—Dactinomycin—germ cell cancer	0.000201	0.000703	CcSEcCtD
Paroxetine—TACR1—G alpha (q) signalling events—AVP—germ cell cancer	0.0002	0.00862	CbGpPWpGaD
Paroxetine—Dysuria—Methotrexate—germ cell cancer	0.000199	0.000699	CcSEcCtD
Paroxetine—Paraesthesia—Cisplatin—germ cell cancer	0.000198	0.000695	CcSEcCtD
Paroxetine—Thrombocytopenia—Etoposide—germ cell cancer	0.000198	0.000694	CcSEcCtD
Paroxetine—Tachycardia—Etoposide—germ cell cancer	0.000198	0.000692	CcSEcCtD
Paroxetine—Dyspnoea—Cisplatin—germ cell cancer	0.000197	0.00069	CcSEcCtD
Paroxetine—TACR1—Peptide ligand-binding receptors—AVP—germ cell cancer	0.000197	0.00851	CbGpPWpGaD
Paroxetine—Skin disorder—Etoposide—germ cell cancer	0.000197	0.000689	CcSEcCtD
Paroxetine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000196	0.000688	CcSEcCtD
Paroxetine—Hyperhidrosis—Etoposide—germ cell cancer	0.000196	0.000686	CcSEcCtD
Paroxetine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000195	0.000682	CcSEcCtD
Paroxetine—TACR1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000193	0.00833	CbGpPWpGaD
Paroxetine—Decreased appetite—Cisplatin—germ cell cancer	0.000192	0.000673	CcSEcCtD
Paroxetine—Diarrhoea—Dactinomycin—germ cell cancer	0.000191	0.000671	CcSEcCtD
Paroxetine—Pneumonia—Methotrexate—germ cell cancer	0.000191	0.00067	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000191	0.000668	CcSEcCtD
Paroxetine—Vomiting—Bleomycin—germ cell cancer	0.000191	0.000668	CcSEcCtD
Paroxetine—Drowsiness—Methotrexate—germ cell cancer	0.00019	0.000666	CcSEcCtD
Paroxetine—Depression—Methotrexate—germ cell cancer	0.00019	0.000664	CcSEcCtD
Paroxetine—Hypotension—Etoposide—germ cell cancer	0.000189	0.000663	CcSEcCtD
Paroxetine—Rash—Bleomycin—germ cell cancer	0.000189	0.000663	CcSEcCtD
Paroxetine—Pain—Cisplatin—germ cell cancer	0.000189	0.000662	CcSEcCtD
Paroxetine—Dermatitis—Bleomycin—germ cell cancer	0.000189	0.000662	CcSEcCtD
Paroxetine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000189	0.000662	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000189	0.00066	CcSEcCtD
Paroxetine—ABCB1—endocrine gland—germ cell cancer	0.000188	0.0011	CbGeAlD
Paroxetine—CYP2D6—brain—germ cell cancer	0.000187	0.00109	CbGeAlD
Paroxetine—ABCB1—head—germ cell cancer	0.000186	0.00108	CbGeAlD
Paroxetine—Stomatitis—Methotrexate—germ cell cancer	0.000185	0.000649	CcSEcCtD
Paroxetine—Conjunctivitis—Methotrexate—germ cell cancer	0.000185	0.000647	CcSEcCtD
Paroxetine—Asthenia—Ifosfamide—germ cell cancer	0.000184	0.000644	CcSEcCtD
Paroxetine—Sweating—Methotrexate—germ cell cancer	0.000182	0.000639	CcSEcCtD
Paroxetine—Feeling abnormal—Cisplatin—germ cell cancer	0.000182	0.000638	CcSEcCtD
Paroxetine—Paraesthesia—Etoposide—germ cell cancer	0.000182	0.000637	CcSEcCtD
Paroxetine—Pruritus—Ifosfamide—germ cell cancer	0.000181	0.000635	CcSEcCtD
Paroxetine—Haematuria—Methotrexate—germ cell cancer	0.000181	0.000635	CcSEcCtD
Paroxetine—Dyspnoea—Etoposide—germ cell cancer	0.000181	0.000632	CcSEcCtD
Paroxetine—Somnolence—Etoposide—germ cell cancer	0.00018	0.000631	CcSEcCtD
Paroxetine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00018	0.00063	CcSEcCtD
Paroxetine—Epistaxis—Methotrexate—germ cell cancer	0.000179	0.000628	CcSEcCtD
Paroxetine—ABCB1—testis—germ cell cancer	0.000179	0.00105	CbGeAlD
Paroxetine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000178	0.00771	CbGpPWpGaD
Paroxetine—Nausea—Bleomycin—germ cell cancer	0.000178	0.000624	CcSEcCtD
Paroxetine—Vomiting—Dactinomycin—germ cell cancer	0.000178	0.000623	CcSEcCtD
Paroxetine—Agranulocytosis—Methotrexate—germ cell cancer	0.000177	0.000622	CcSEcCtD
Paroxetine—Rash—Dactinomycin—germ cell cancer	0.000176	0.000618	CcSEcCtD
Paroxetine—Decreased appetite—Etoposide—germ cell cancer	0.000176	0.000617	CcSEcCtD
Paroxetine—Diarrhoea—Ifosfamide—germ cell cancer	0.000175	0.000614	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000175	0.000612	CcSEcCtD
Paroxetine—Body temperature increased—Cisplatin—germ cell cancer	0.000175	0.000612	CcSEcCtD
Paroxetine—Fatigue—Etoposide—germ cell cancer	0.000175	0.000611	CcSEcCtD
Paroxetine—Constipation—Etoposide—germ cell cancer	0.000173	0.000607	CcSEcCtD
Paroxetine—Pain—Etoposide—germ cell cancer	0.000173	0.000607	CcSEcCtD
Paroxetine—Haemoglobin—Methotrexate—germ cell cancer	0.000172	0.000601	CcSEcCtD
Paroxetine—Hepatitis—Methotrexate—germ cell cancer	0.000171	0.000598	CcSEcCtD
Paroxetine—Haemorrhage—Methotrexate—germ cell cancer	0.000171	0.000598	CcSEcCtD
Paroxetine—Dizziness—Ifosfamide—germ cell cancer	0.00017	0.000594	CcSEcCtD
Paroxetine—Pharyngitis—Methotrexate—germ cell cancer	0.000169	0.000593	CcSEcCtD
Paroxetine—Feeling abnormal—Etoposide—germ cell cancer	0.000167	0.000584	CcSEcCtD
Paroxetine—Nausea—Dactinomycin—germ cell cancer	0.000166	0.000582	CcSEcCtD
Paroxetine—ABCB1—cerebellum—germ cell cancer	0.000166	0.000967	CbGeAlD
Paroxetine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000166	0.00058	CcSEcCtD
Paroxetine—Visual impairment—Methotrexate—germ cell cancer	0.000165	0.000576	CcSEcCtD
Paroxetine—Vomiting—Ifosfamide—germ cell cancer	0.000163	0.000571	CcSEcCtD
Paroxetine—Hypersensitivity—Cisplatin—germ cell cancer	0.000163	0.00057	CcSEcCtD
Paroxetine—Rash—Ifosfamide—germ cell cancer	0.000162	0.000566	CcSEcCtD
Paroxetine—Dermatitis—Ifosfamide—germ cell cancer	0.000161	0.000566	CcSEcCtD
Paroxetine—Erythema multiforme—Methotrexate—germ cell cancer	0.000161	0.000565	CcSEcCtD
Paroxetine—Urticaria—Etoposide—germ cell cancer	0.000161	0.000563	CcSEcCtD
Paroxetine—Abdominal pain—Etoposide—germ cell cancer	0.00016	0.000561	CcSEcCtD
Paroxetine—Body temperature increased—Etoposide—germ cell cancer	0.00016	0.000561	CcSEcCtD
Paroxetine—Eye disorder—Methotrexate—germ cell cancer	0.00016	0.000559	CcSEcCtD
Paroxetine—Tinnitus—Methotrexate—germ cell cancer	0.000159	0.000558	CcSEcCtD
Paroxetine—Asthenia—Cisplatin—germ cell cancer	0.000159	0.000555	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—germ cell cancer	0.000158	0.000555	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—germ cell cancer	0.000155	0.000543	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—germ cell cancer	0.000154	0.00054	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000154	0.000539	CcSEcCtD
Paroxetine—Chills—Methotrexate—germ cell cancer	0.000153	0.000537	CcSEcCtD
Paroxetine—Nausea—Ifosfamide—germ cell cancer	0.000152	0.000533	CcSEcCtD
Paroxetine—Diarrhoea—Cisplatin—germ cell cancer	0.000151	0.00053	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—germ cell cancer	0.000151	0.000528	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—germ cell cancer	0.00015	0.000524	CcSEcCtD
Paroxetine—Hypersensitivity—Etoposide—germ cell cancer	0.000149	0.000523	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—germ cell cancer	0.000149	0.000521	CcSEcCtD
Paroxetine—Erythema—Methotrexate—germ cell cancer	0.000149	0.000521	CcSEcCtD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000148	0.00639	CbGpPWpGaD
Paroxetine—TACR1—GPCR ligand binding—OXT—germ cell cancer	0.000147	0.00634	CbGpPWpGaD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000146	0.00629	CbGpPWpGaD
Paroxetine—Dysgeusia—Methotrexate—germ cell cancer	0.000146	0.00051	CcSEcCtD
Paroxetine—Asthenia—Etoposide—germ cell cancer	0.000145	0.000509	CcSEcCtD
Paroxetine—Back pain—Methotrexate—germ cell cancer	0.000144	0.000504	CcSEcCtD
Paroxetine—Pruritus—Etoposide—germ cell cancer	0.000143	0.000502	CcSEcCtD
Paroxetine—Vomiting—Cisplatin—germ cell cancer	0.000141	0.000492	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—germ cell cancer	0.00014	0.000491	CcSEcCtD
Paroxetine—Rash—Cisplatin—germ cell cancer	0.000139	0.000488	CcSEcCtD
Paroxetine—Dermatitis—Cisplatin—germ cell cancer	0.000139	0.000488	CcSEcCtD
Paroxetine—Diarrhoea—Etoposide—germ cell cancer	0.000139	0.000485	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000138	0.000483	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—germ cell cancer	0.000137	0.000481	CcSEcCtD
Paroxetine—CHRM4—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000137	0.00591	CbGpPWpGaD
Paroxetine—ABCB1—brain—germ cell cancer	0.000135	0.000785	CbGeAlD
Paroxetine—Malaise—Methotrexate—germ cell cancer	0.000134	0.000469	CcSEcCtD
Paroxetine—Dizziness—Etoposide—germ cell cancer	0.000134	0.000469	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—germ cell cancer	0.000134	0.000468	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—germ cell cancer	0.000133	0.000466	CcSEcCtD
Paroxetine—TACR1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000132	0.00571	CbGpPWpGaD
Paroxetine—Nausea—Cisplatin—germ cell cancer	0.000131	0.00046	CcSEcCtD
Paroxetine—CHRM5—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	0.000131	0.00566	CbGpPWpGaD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000131	0.00566	CbGpPWpGaD
Paroxetine—ABCB1—lymph node—germ cell cancer	0.00013	0.000759	CbGeAlD
Paroxetine—Cough—Methotrexate—germ cell cancer	0.00013	0.000454	CcSEcCtD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000129	0.00557	CbGpPWpGaD
Paroxetine—Convulsion—Methotrexate—germ cell cancer	0.000129	0.000451	CcSEcCtD
Paroxetine—Vomiting—Etoposide—germ cell cancer	0.000129	0.000451	CcSEcCtD
Paroxetine—CHRM5—G alpha (q) signalling events—OXT—germ cell cancer	0.000128	0.00553	CbGpPWpGaD
Paroxetine—Rash—Etoposide—germ cell cancer	0.000128	0.000447	CcSEcCtD
Paroxetine—Dermatitis—Etoposide—germ cell cancer	0.000128	0.000447	CcSEcCtD
Paroxetine—Headache—Etoposide—germ cell cancer	0.000127	0.000444	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—germ cell cancer	0.000127	0.000443	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—germ cell cancer	0.000127	0.000443	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—germ cell cancer	0.000127	0.000443	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000126	0.00044	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—germ cell cancer	0.000125	0.000438	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—germ cell cancer	0.000122	0.000428	CcSEcCtD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000122	0.00526	CbGpPWpGaD
Paroxetine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000121	0.000425	CcSEcCtD
Paroxetine—Infection—Methotrexate—germ cell cancer	0.00012	0.000422	CcSEcCtD
Paroxetine—Nausea—Etoposide—germ cell cancer	0.00012	0.000421	CcSEcCtD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00012	0.00517	CbGpPWpGaD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000119	0.00515	CbGpPWpGaD
Paroxetine—Nervous system disorder—Methotrexate—germ cell cancer	0.000119	0.000417	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000119	0.000416	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—germ cell cancer	0.000118	0.000413	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000117	0.000411	CcSEcCtD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000115	0.00496	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	0.000114	0.00495	CbGpPWpGaD
Paroxetine—Hypotension—Methotrexate—germ cell cancer	0.000113	0.000397	CcSEcCtD
Paroxetine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—germ cell cancer	0.000112	0.00484	CbGpPWpGaD
Paroxetine—TACR1—Spinal Cord Injury—MYC—germ cell cancer	0.000111	0.00479	CbGpPWpGaD
Paroxetine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00011	0.000387	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—germ cell cancer	0.00011	0.000384	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—germ cell cancer	0.000109	0.000381	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—germ cell cancer	0.000108	0.000379	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—germ cell cancer	0.000108	0.000378	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—germ cell cancer	0.000107	0.000374	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—germ cell cancer	0.000105	0.000369	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000105	0.000367	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—germ cell cancer	0.000105	0.000366	CcSEcCtD
Paroxetine—Pain—Methotrexate—germ cell cancer	0.000104	0.000363	CcSEcCtD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000102	0.00439	CbGpPWpGaD
Paroxetine—TACR1—GPCR ligand binding—AVP—germ cell cancer	0.000101	0.00435	CbGpPWpGaD
Paroxetine—Feeling abnormal—Methotrexate—germ cell cancer	9.99e-05	0.00035	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—germ cell cancer	9.92e-05	0.000347	CcSEcCtD
Paroxetine—SLC6A4—Circadian rythm related genes—AVP—germ cell cancer	9.74e-05	0.00421	CbGpPWpGaD
Paroxetine—Urticaria—Methotrexate—germ cell cancer	9.63e-05	0.000337	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—germ cell cancer	9.59e-05	0.000336	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—germ cell cancer	9.59e-05	0.000336	CcSEcCtD
Paroxetine—CHRM1—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	9.23e-05	0.00399	CbGpPWpGaD
Paroxetine—CHRM3—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	9.2e-05	0.00397	CbGpPWpGaD
Paroxetine—CHRM2—Regulation of Actin Cytoskeleton—FGF4—germ cell cancer	9.11e-05	0.00394	CbGpPWpGaD
Paroxetine—TACR1—Spinal Cord Injury—TP53—germ cell cancer	9.1e-05	0.00393	CbGpPWpGaD
Paroxetine—HTR2A—G alpha (q) signalling events—OXT—germ cell cancer	9.06e-05	0.00392	CbGpPWpGaD
Paroxetine—CHRM1—G alpha (q) signalling events—OXT—germ cell cancer	9.01e-05	0.00389	CbGpPWpGaD
Paroxetine—CHRM3—G alpha (q) signalling events—OXT—germ cell cancer	8.99e-05	0.00388	CbGpPWpGaD
Paroxetine—Hypersensitivity—Methotrexate—germ cell cancer	8.94e-05	0.000313	CcSEcCtD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	8.85e-05	0.00383	CbGpPWpGaD
Paroxetine—CHRM5—G alpha (q) signalling events—AVP—germ cell cancer	8.77e-05	0.00379	CbGpPWpGaD
Paroxetine—Asthenia—Methotrexate—germ cell cancer	8.7e-05	0.000305	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—germ cell cancer	8.58e-05	0.000301	CcSEcCtD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	8.48e-05	0.00366	CbGpPWpGaD
Paroxetine—CHRM4—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	8.36e-05	0.00361	CbGpPWpGaD
Paroxetine—Diarrhoea—Methotrexate—germ cell cancer	8.3e-05	0.000291	CcSEcCtD
Paroxetine—TACR1—GPCR downstream signaling—OXT—germ cell cancer	8.3e-05	0.00359	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	8.11e-05	0.0035	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	8.06e-05	0.00348	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	8.04e-05	0.00347	CbGpPWpGaD
Paroxetine—Dizziness—Methotrexate—germ cell cancer	8.02e-05	0.000281	CcSEcCtD
Paroxetine—CHRM5—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	8e-05	0.00346	CbGpPWpGaD
Paroxetine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	7.96e-05	0.00344	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	7.85e-05	0.00339	CbGpPWpGaD
Paroxetine—Vomiting—Methotrexate—germ cell cancer	7.71e-05	0.00027	CcSEcCtD
Paroxetine—Rash—Methotrexate—germ cell cancer	7.65e-05	0.000268	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—germ cell cancer	7.64e-05	0.000268	CcSEcCtD
Paroxetine—Headache—Methotrexate—germ cell cancer	7.6e-05	0.000266	CcSEcCtD
Paroxetine—TACR1—Signaling by GPCR—OXT—germ cell cancer	7.54e-05	0.00326	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.51e-05	0.00325	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.4e-05	0.0032	CbGpPWpGaD
Paroxetine—Nausea—Methotrexate—germ cell cancer	7.2e-05	0.000252	CcSEcCtD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—AVP—germ cell cancer	7.18e-05	0.0031	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—AVP—germ cell cancer	7.05e-05	0.00305	CbGpPWpGaD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.82e-05	0.00295	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—OXT—germ cell cancer	6.74e-05	0.00291	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.65e-05	0.00288	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.55e-05	0.00283	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—OXT—germ cell cancer	6.46e-05	0.00279	CbGpPWpGaD
Paroxetine—HTR2A—G alpha (q) signalling events—AVP—germ cell cancer	6.21e-05	0.00268	CbGpPWpGaD
Paroxetine—CHRM1—G alpha (q) signalling events—AVP—germ cell cancer	6.18e-05	0.00267	CbGpPWpGaD
Paroxetine—CHRM3—G alpha (q) signalling events—AVP—germ cell cancer	6.16e-05	0.00266	CbGpPWpGaD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	6.07e-05	0.00262	CbGpPWpGaD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	6.04e-05	0.00261	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	6e-05	0.00259	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.97e-05	0.00258	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.95e-05	0.00257	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	5.89e-05	0.00255	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—AVP—germ cell cancer	5.83e-05	0.00252	CbGpPWpGaD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.81e-05	0.00251	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—AVP—germ cell cancer	5.69e-05	0.00246	CbGpPWpGaD
Paroxetine—CHRM1—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	5.63e-05	0.00243	CbGpPWpGaD
Paroxetine—CHRM3—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	5.62e-05	0.00243	CbGpPWpGaD
Paroxetine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	5.56e-05	0.0024	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	5.56e-05	0.0024	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	5.53e-05	0.00239	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	5.51e-05	0.00238	CbGpPWpGaD
Paroxetine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.38e-05	0.00233	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—AVP—germ cell cancer	5.16e-05	0.00223	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	5.06e-05	0.00218	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—AVP—germ cell cancer	4.62e-05	0.002	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—OXT—germ cell cancer	4.57e-05	0.00197	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—OXT—germ cell cancer	4.55e-05	0.00196	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—OXT—germ cell cancer	4.53e-05	0.00196	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—OXT—germ cell cancer	4.49e-05	0.00194	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—OXT—germ cell cancer	4.45e-05	0.00192	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—AVP—germ cell cancer	4.43e-05	0.00191	CbGpPWpGaD
Paroxetine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	4.38e-05	0.00189	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.11e-05	0.00178	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.09e-05	0.00177	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.08e-05	0.00176	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.04e-05	0.00175	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—OXT—germ cell cancer	3.81e-05	0.00165	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—FGF4—germ cell cancer	3.8e-05	0.00164	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—OXT—germ cell cancer	3.65e-05	0.00158	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—AVP—germ cell cancer	3.46e-05	0.0015	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—OXT—germ cell cancer	3.46e-05	0.00149	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—H2AFZ—germ cell cancer	3.39e-05	0.00147	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—OXT—germ cell cancer	3.31e-05	0.00143	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	3.31e-05	0.00143	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	3.26e-05	0.00141	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.21e-05	0.00139	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—AVP—germ cell cancer	3.13e-05	0.00135	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—KITLG—germ cell cancer	3.12e-05	0.00135	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—AVP—germ cell cancer	3.12e-05	0.00135	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—AVP—germ cell cancer	3.11e-05	0.00134	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—AVP—germ cell cancer	3.08e-05	0.00133	CbGpPWpGaD
Paroxetine—SLC6A4—Circadian rythm related genes—TP53—germ cell cancer	3.07e-05	0.00133	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—AVP—germ cell cancer	3.07e-05	0.00133	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—AVP—germ cell cancer	3.05e-05	0.00132	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—AVP—germ cell cancer	2.61e-05	0.00113	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.61e-05	0.00113	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—OXT—germ cell cancer	2.58e-05	0.00112	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—OXT—germ cell cancer	2.57e-05	0.00111	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—OXT—germ cell cancer	2.56e-05	0.00111	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—OXT—germ cell cancer	2.54e-05	0.0011	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—AVP—germ cell cancer	2.5e-05	0.00108	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—SLC2A3—germ cell cancer	2.44e-05	0.00105	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—SLC22A3—germ cell cancer	2.4e-05	0.00104	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—AVP—germ cell cancer	2.37e-05	0.00102	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.37e-05	0.00102	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—OXT—germ cell cancer	2.35e-05	0.00101	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—OXT—germ cell cancer	2.33e-05	0.00101	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—OXT—germ cell cancer	2.33e-05	0.001	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—FGFR3—germ cell cancer	2.32e-05	0.001	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—OXT—germ cell cancer	2.3e-05	0.000995	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AVP—germ cell cancer	2.27e-05	0.000981	CbGpPWpGaD
Paroxetine—SLC6A3—Transmission across Chemical Synapses—HRAS—germ cell cancer	2.25e-05	0.000971	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—KIT—germ cell cancer	2.13e-05	0.00092	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—SLC2A3—germ cell cancer	2.1e-05	0.000908	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—SLC22A3—germ cell cancer	2.07e-05	0.000894	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—OXT—germ cell cancer	2.04e-05	0.000883	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CRABP1—germ cell cancer	1.96e-05	0.000847	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—OXT—germ cell cancer	1.96e-05	0.000846	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—germ cell cancer	1.84e-05	0.000795	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—SLC2A3—germ cell cancer	1.78e-05	0.000768	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AVP—germ cell cancer	1.77e-05	0.000765	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AVP—germ cell cancer	1.76e-05	0.000761	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AVP—germ cell cancer	1.76e-05	0.000758	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—SLC22A3—germ cell cancer	1.75e-05	0.000757	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—FGF4—germ cell cancer	1.74e-05	0.000754	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AVP—germ cell cancer	1.74e-05	0.000751	CbGpPWpGaD
Paroxetine—SLC6A3—Neuronal System—HRAS—germ cell cancer	1.72e-05	0.000744	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CRABP1—germ cell cancer	1.69e-05	0.000729	CbGpPWpGaD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.68e-05	0.000724	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—FGF4—germ cell cancer	1.67e-05	0.000722	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.67e-05	0.00072	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	1.66e-05	0.000718	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AVP—germ cell cancer	1.61e-05	0.000695	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AVP—germ cell cancer	1.6e-05	0.000691	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AVP—germ cell cancer	1.59e-05	0.000689	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AVP—germ cell cancer	1.58e-05	0.000682	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—HRAS—germ cell cancer	1.56e-05	0.000673	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—H2AFZ—germ cell cancer	1.56e-05	0.000673	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.55e-05	0.000669	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.53e-05	0.000659	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.53e-05	0.000659	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—H2AFZ—germ cell cancer	1.49e-05	0.000645	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.48e-05	0.000638	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.46e-05	0.000631	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—SLC2A3—germ cell cancer	1.45e-05	0.000625	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.44e-05	0.000621	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—KITLG—germ cell cancer	1.43e-05	0.000619	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CRABP1—germ cell cancer	1.43e-05	0.000617	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—SLC22A3—germ cell cancer	1.43e-05	0.000616	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AVP—germ cell cancer	1.4e-05	0.000605	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—OXT—germ cell cancer	1.39e-05	0.000599	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—OXT—germ cell cancer	1.38e-05	0.000595	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—OXT—germ cell cancer	1.37e-05	0.000594	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—KITLG—germ cell cancer	1.37e-05	0.000593	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—OXT—germ cell cancer	1.36e-05	0.000588	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AVP—germ cell cancer	1.34e-05	0.00058	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CRABP1—germ cell cancer	1.24e-05	0.000538	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.21e-05	0.000524	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FGF4—germ cell cancer	1.18e-05	0.000511	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FGF4—germ cell cancer	1.18e-05	0.000508	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FGF4—germ cell cancer	1.17e-05	0.000507	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.17e-05	0.000507	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MYC—germ cell cancer	1.17e-05	0.000506	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CRABP1—germ cell cancer	1.16e-05	0.000502	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FGF4—germ cell cancer	1.16e-05	0.000502	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—FGFR3—germ cell cancer	1.07e-05	0.00046	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—H2AFZ—germ cell cancer	1.06e-05	0.000456	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—H2AFZ—germ cell cancer	1.05e-05	0.000454	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—H2AFZ—germ cell cancer	1.05e-05	0.000452	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—H2AFZ—germ cell cancer	1.04e-05	0.000448	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—FGFR3—germ cell cancer	1.02e-05	0.000441	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—KIT—germ cell cancer	9.78e-06	0.000423	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—KITLG—germ cell cancer	9.72e-06	0.00042	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—KITLG—germ cell cancer	9.66e-06	0.000418	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—KITLG—germ cell cancer	9.63e-06	0.000416	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—germ cell cancer	9.62e-06	0.000416	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—KITLG—germ cell cancer	9.54e-06	0.000412	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AVP—germ cell cancer	9.5e-06	0.00041	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AVP—germ cell cancer	9.45e-06	0.000408	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AVP—germ cell cancer	9.42e-06	0.000407	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—KIT—germ cell cancer	9.37e-06	0.000405	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AVP—germ cell cancer	9.32e-06	0.000403	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—HRAS—germ cell cancer	9.2e-06	0.000398	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FGFR3—germ cell cancer	7.22e-06	0.000312	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FGFR3—germ cell cancer	7.18e-06	0.00031	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FGFR3—germ cell cancer	7.16e-06	0.000309	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—HRAS—germ cell cancer	7.15e-06	0.000309	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FGFR3—germ cell cancer	7.09e-06	0.000306	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—HRAS—germ cell cancer	6.85e-06	0.000296	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—KIT—germ cell cancer	6.63e-06	0.000286	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—KIT—germ cell cancer	6.59e-06	0.000285	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—KIT—germ cell cancer	6.57e-06	0.000284	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—KIT—germ cell cancer	6.51e-06	0.000281	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MYC—germ cell cancer	5.38e-06	0.000233	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MYC—germ cell cancer	5.15e-06	0.000223	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—HRAS—germ cell cancer	4.85e-06	0.00021	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—HRAS—germ cell cancer	4.82e-06	0.000208	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—HRAS—germ cell cancer	4.81e-06	0.000208	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—HRAS—germ cell cancer	4.76e-06	0.000206	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—germ cell cancer	4.42e-06	0.000191	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—germ cell cancer	4.23e-06	0.000183	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HRAS—germ cell cancer	4.23e-06	0.000183	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HRAS—germ cell cancer	4.05e-06	0.000175	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MYC—germ cell cancer	3.65e-06	0.000158	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MYC—germ cell cancer	3.63e-06	0.000157	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MYC—germ cell cancer	3.62e-06	0.000156	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MYC—germ cell cancer	3.58e-06	0.000155	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—germ cell cancer	3e-06	0.000129	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—germ cell cancer	2.98e-06	0.000129	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—germ cell cancer	2.97e-06	0.000128	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—germ cell cancer	2.94e-06	0.000127	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HRAS—germ cell cancer	2.87e-06	0.000124	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HRAS—germ cell cancer	2.85e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HRAS—germ cell cancer	2.84e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HRAS—germ cell cancer	2.81e-06	0.000122	CbGpPWpGaD
